Institute of Virology, Vaccines and Sera, Torlak Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2015
NCT02585700
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

phosphate (2 trials)

Drugs in Phase 1 Trials (1)

inactivated influenza vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2